APRE vs JLL · $10.4M cap vs P/E 23, rev $13.31B
Aprea Therapeutics Inc (APRE) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
APRE does not have a complete income-statement cache yet.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
APRE currently screens at market cap $10.4M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the APRE and JLL stock pages for the full models.
Not investment advice.